All lobbying filings

CAPITOL HILL CONSULTING GROUP

Lobbying for HUMACYTE · Biotechnology platform for vascular diseases.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · North Carolina · House · Senate · $50,000.00 income · posted Jan 20, 2026

Official filing document

Lobbying activity 3

Medicare/Medicaid

Issues related to Medicare reimbursement for biological products.

Health Issues

Issues related to Medicare reimbursement for biological products. Issues related to supporting access to biologic products to treat warfighters.

Defense

Supporting funding for procurement of biologic products to treat post-combat trauma. Issues related to supporting access to biologic products to treat warfighters.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.